88-gene cfRNA assay for detection of gene fusions and splicing variants

• Covers 88 genes

• Detects RNA-specific splicing variants

• Detects known and novel fusions

• Confirms and extends DNA-based variant detection

Fusion detection by PredicineRNA

Features and benefits

Comprehensive fusion detection

Identifies known and novel fusion genes

Splice variants

Detection of novel splicing events that cannot be seen at the DNA level

High Sensitivity Predicine

Low Input

Efficient capture of cfRNA from as little as 2 mL of plasma

Compatible with liquid biopsy

Liquid biopsy including low-input samples

Sample types

Whole blood

Sample requirements

2-5 mL plasma
4-10 mL whole blood

Turnaround time

14 days


PredicineATLAS workflow

PredicineRNA™ is a laboratory developed test. It is for research use only. 


Our pilot program is available to select biopharma and academic partners to accelerate biomarker discoveries and biomarker-driven clinical studies.  To initiate a study, contact us via the form below.

Contact us

If you have any questions or need assistance, complete this form and we will respond within 24 hours.